Factor VIIa for severe cardiac surgical bleeding
Open Access
- 1 January 2002
- Published by Springer Nature in Critical Care
- Vol. 6 (Suppl 2) , 6
- https://doi.org/10.1186/cc1810
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VIIAnesthesia & Analgesia, 2001
- Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgeryBlood Coagulation & Fibrinolysis, 2000
- SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMYThe Lancet, 1988